The average daily volume (ADV) of European derivatives traded on NYSE Euronext in April was 6.8 million fontracts, an increase of 51.5 per cent over April 2009 and an increase of 46.9 per cent from March 2010 levels.
The 6.8 million in futures and options contracts ADV consisted of 3.9 million contracts executed through NYSE Euronext’s full-service LIFFE CONNECT trading platform and 2.9 million contracts, or 42.0%, executed through Bclear, NYSE Liffe’s trade administration and clearing service for OTC products. Year-to-date, European derivatives products ADV of 5.3 million contracts was 34.7% above prior year levels. The 5.3 million in futures and options contracts ADV year-to-date consisted of 3.9 million contracts executed through LIFFE CONNECT trading platform and 1.4 million contracts, or 26.8%, executed through Bclear.
On April 28, 2010, NYSE Liffe set a new total exchange record for derivative contracts traded of 12.4 million contracts in a single day, 7% above the previous record of 11.6 million contracts recorded on December 18, 2008.
The ADV of total European fixed income products ADV in April 2010 of 2.8 million contracts increased 46.5% compared to April 2009 and increased 4.7% from March 2010. Total equity products ADV of 4.0 million contracts in April 2010 increased 56.2% compared to April 2009 and increased 105.0% from March 2010.
Total equity products (including Bclear) ADV of 4.0 million contracts in April 2010 increased 56.2% compared to April 2009 and increased 105.0% from March 2010. The 4.0 million contracts in equity products ADV consisted of 3.4 million contracts in individual equity products ADV and 0.6 million contracts in equity index products ADV.
The 3.4 million contracts in individual equity products ADV consisted of 2.6 million in futures contracts, which represented a 93.7% increase compared to April 2009 and 0.7 million in options contracts, which represented a 33.9% increase compared to April 2009. The rate per contract for individual equity futures contracts is significantly lower than other products traded on NYSE Liffe. Year-to-date, total equity products ADV of 2.5 million contracts was 31.1% above prior year levels.
Total commodities products ADV of 57,000 contracts in April 2010 increased 7.4% compared to April 2009 and increased 10.9% from March 2010. Year-to-date, total commodities product ADV of 53,000 contracts was 12.4% above prior year levels.
NYSE Euronext US equity options (NYSE Arca and NYSE Amex) ADV of 4.0 million contracts in April 2010 increased 62.3% compared to April 2009 and increased 12.8% compared to March 2010. Year-to-date, US equity options ADV of 3.8 million contracts was 62.7% above prior year levels.
Total US consolidated equity options ADV increased 9.1% to 15.8 million contracts in April 2010 compared to April 2009 and increased 12.5% compared to March 2010. Year-to-date, U.S. consolidated equity options ADV of 14.4 million contracts was 7.2% above prior year levels.
NYSE Euronext’s US options exchanges accounted for 25.3% of the total consolidated equity options trading in April 2010, up from 17.0% in April 2009 and in-line with the 25.3% in March 2010. US futures and futures options (NYSE Liffe U.S.) ADV in April 2010 was approximately 19,000 contracts, compared to 18,000 contracts in March 2010. Year-to-date U.S. futures and futures options ADV was 20,000 contracts.
European cash products ADV of 1.6 million transactions in April 2010 decreased 0.2%, compared to April 2009, but increased 22.2% compared to March 2010. Year-to-date, European cash products ADV of 1.4 million transactions was 0.4% below prior year levels.
NYSE Euronext US matched exchange-traded products ADV (included in volumes for Tape B and Tape C) of 326 million shares in April 2010 decreased 42.8% compared to April 2009, but increased 19.9% compared to March 2010. Year-to-date, NYSE Euronext U.S. matched exchange-traded products ADV of 325 million shares was 45.9% below prior year levels.
NYSE Euronext US cash products handled ADV in April 2010 decreased 26.6% to 2.9 billion shares compared to April 2009, but increased 21.4% from March 2010. Year-to-date, US cash products handled ADV was 2.6 billion shares, down 34.3% from prior year levels.
NYSE Euronext’s Tape A matched market share in April 2010 was 34.1%, up from 33.6% in March 2010.
Designated Market Maker participation in April 2010 was 9.5%, compared to 8.5% in March 2010. Supplemental Liquidity Provider participation in April 2010 was 12.0%, compared to 11.4% in March 2010. DMM and SLP participation pertain only to trading on NYSE.
